Charles Zacharchuk
Inventor
Stats
- 0 US patents issued
- 5 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 5 US Applications Filed
- 31 Total Citation Count
- Apr 30, 2013 Most Recent Filing
- Nov 2, 2006 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| WYETH LLC | 2
1 1 | 2009
2012 2013 |
| WYETH | 1
| 2006
|
Inventor Addresses
| Address | Duration |
|---|---|
| Westford, MA | May 10, 07 - May 10, 07 |
| Westford, MA, US | Dec 03, 09 - Aug 04, 20 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| C12Q: | MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 10729672 | 2020 | Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272 | 0 |
| 2014/0050,721 | 2014 | Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272 | 13 |
| 2012/0308,560 | 2012 | Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272 | 12 |
| 2010/0081,666 | 2010 | SRC ACTIVATION FOR DETERMINING CANCER PROGNOSIS AND AS A TARGET FOR CANCER THERAPY | 1 |
| 2009/0297,519 | 2009 | ANTINEOPLASTIC COMBINATIONS WITH mTOR INHIBITOR, TRASTUZUMAB, AND/OR HKI-272 | 11 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.